Osteoblastic Wnts differentially regulate bone remodeling and the maintenance of bone marrow mesenchymal stem cells

Bone

Volumn 55, Issue 1, 2013, Pages 258-267

  Wan, Yong ^a   Lu, Cheng ^a   Cao, Jingjing ^a   Zhou, Rujiang ^a   Yao, Yiyun ^a   Yu, Jian ^a   Zhang, Lingling ^a   Zhao, Haixia ^a   Li, Hanjun ^a   Zhao, Jianzhi ^a   Zhu, Xuming ^a   He, Lin ^a   Liu, Yongzhong ^b   Yao, Zhengju ^a   Yang, Xiao ^c   Guo, Xizhi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI CANCER INSTITUTE   (China)

^c BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

Author keywords

BMSCs; Bone remodeling; Osteoblast; Osteoclast; Wnt

Indexed keywords

WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA CATENIN GENE; BONE CHARACTERISTICS AND FUNCTIONS; BONE MARROW CELL; BONE MASS; BONE REMODELING; CONTROLLED STUDY; GENE; GENE INACTIVATION; LRP5 GENE; MALE; MESENCHYMAL STEM CELL; NEWBORN; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOBLAST PROGENITOR CELL; OSTEOBLASTOGENESIS; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPENIA; PROTEIN FUNCTION; PROTEIN SECRETION; WNTLESS GENE;

ANIMALS; ANIMALS, NEWBORN; BONE AND BONES; BONE DISEASES, METABOLIC; BONE MARROW CELLS; BONE REMODELING; CELL DIFFERENTIATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGE COLONY-STIMULATING FACTOR; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; ORGAN SIZE; OSTEOBLASTS; OSTEOGENESIS; PARACRINE COMMUNICATION; RANK LIGAND; RECEPTORS, G-PROTEIN-COUPLED; WNT PROTEINS; X-RAY MICROTOMOGRAPHY;

EID: 84877623628     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.12.052     Document Type: Article

References (52)

1. Harada S., Rodan G.A. Control of osteoblast function and regulation of bone mass. Nature 2003, 423:349-355.
2. Tang Y., Wu X., Lei W., Pang L., Wan C., Shi Z., et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 2009, 15:757-765.
3. Glass D.A., Bialek P., Ahn J.D., Starbuck M., Patel M.S., Clevers H., et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 2005, 8:751-764.
4. Holmen S.L., Zylstra C.R., Mukherjee A., Sigler R.E., Faugere M.C., Bouxsein M.L., et al. Essential role of beta-catenin in postnatal bone acquisition. J Biol Chem 2005, 280:21162-21168.
5. Kramer I., Halleux C., Keller H., Pegurri M., Gooi J.H., Weber P.B., et al. Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis. Mol Cell Biol 2010, 30:3071-3085.
6. Spencer G.J., Utting J.C., Etheridge S.L., Arnett T.R., Genever P.G. Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro. J Cell Sci 2006, 119:1283-1296.
7. Shin C.S., Her S.J., Kim J.A., Kim D.H., Kim S.W., Kim S.Y., et al. Dominant negative N-cadherin inhibits osteoclast differentiation by interfering with beta-catenin regulation of RANKL, independent of cell-cell adhesion. J Bone Miner Res 2005, 20:2200-2212.
8. Nakashima T., Hayashi M., Fukunaga T., Kurata K., Oh-Hora M., Feng J.Q., et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med 2011, 17:1231-1234.
9. Zhao C., Irie N., Takada Y., Shimoda K., Miyamoto T., Nishiwaki T., et al. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab 2006, 4:111-121.
10. Irie N., Takada Y., Watanabe Y., Matsuzaki Y., Naruse C., Asano M., et al. Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis. J Biol Chem 2009, 284:14637-14644.
11. Hayashi M., Nakashima T., Taniguchi M., Kodama T., Kumanogoh A., Takayanagi H. Osteoprotection by semaphorin 3A. Nature 2012, 485:69-74.
12. Negishi-Koga T., Shinohara M., Komatsu N., Bito H., Kodama T., Friedel R.H., et al. Suppression of bone formation by osteoclastic expression of semaphorin 4D. Nat Med 2011, 17:1473-1480.
13. Kato M., Patel M.S., Levasseur R., Lobov I., Chang B.H., Glass D.A., et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 2002, 157:303-314.
14. Bodine P.V., Zhao W., Kharode Y.P., Bex F.J., Lambert A.J., Goad M.B., et al. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol 2004, 18:1222-1237.
15. Cui Y., Niziolek P.J., MacDonald B.T., Zylstra C.R., Alenina N., Robinson D.R., et al. Lrp5 functions in bone to regulate bone mass. Nat Med 2011, 17:684-691.
16. Joeng K.S., Schumacher C.A., Zylstra-Diegel C.R., Long F., Williams B.O. Lrp5 and Lrp6 redundantly control skeletal development in the mouse embryo. Dev Biol 2011, 359:222-229.
17. Stevens J.R., Miranda-Carboni G.A., Singer M.A., Brugger S.M., Lyons K.M., Lane T.F. Wnt10b deficiency results in age-dependent loss of bone mass and progressive reduction of mesenchymal progenitor cells. J Bone Miner Res 2010, 25:2138-2147.
18. Li X., Ominsky M.S., Niu Q.T., Sun N., Daugherty B., D'Agostin D., et al. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res 2008, 23:860-869.
19. Morvan F., Boulukos K., Clement-Lacroix P., Roman Roman S., Suc-Royer I., Vayssiere B., et al. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res 2006, 21:934-945.
20. Gong Y., Slee R.B., Fukai N., Rawadi G., Roman-Roman S., Reginato A.M., et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001, 107:513-523.
21. Boyden L.M., Mao J., Belsky J., Mitzner L., Farhi A., Mitnick M.A., et al. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 2002, 346:1513-1521.
22. Little R.D., Carulli J.P., Del Mastro R.G., Dupuis J., Osborne M., Folz C., et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 2002, 70:11-19.
23. Babij P., Zhao W., Small C., Kharode Y., Yaworsky P.J., Bouxsein M.L., et al. High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res 2003, 18:960-974.
24. Rodda S.J., McMahon A.P. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 2006, 133:3231-3244.
25. Day T.F., Guo X., Garrett-Beal L., Yang Y. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 2005, 8:739-750.
26. Hill T.P., Spater D., Taketo M.M., Birchmeier W., Hartmann C. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 2005, 8:727-738.
27. Wei W., Zeve D., Suh J.M., Wang X., Du Y., Zerwekh J.E., et al. Biphasic and dosage-dependent regulation of osteoclastogenesis by beta-catenin. Mol Cell Biol 2011, 31:4706-4719.
28. Yadav V.K., Ryu J.H., Suda N., Tanaka K.F., Gingrich J.A., Schutz G., et al. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 2008, 135:825-837.
29. Takada I., Mihara M., Suzawa M., Ohtake F., Kobayashi S., Igarashi M., et al. A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation. Nat Cell Biol 2007, 9:1273-1285.
30. Tu X., Joeng K.S., Nakayama K.I., Nakayama K., Rajagopal J., Carroll T.J., et al. Noncanonical Wnt signaling through G protein-linked PKCdelta activation promotes bone formation. Dev Cell 2007, 12:113-127.
31. Bennett C.N., Longo K.A., Wright W.S., Suva L.J., Lane T.F., Hankenson K.D., et al. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci USA 2005, 102:3324-3329.
32. Bennett C.N., Ouyang H., Ma Y.L., Zeng Q., Gerin I., Sousa K.M., et al. Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation. J Bone Miner Res 2007, 22:1924-1932.
33. Kim J.B., Leucht P., Lam K., Luppen C., Ten Berge D., Nusse R., et al. Bone regeneration is regulated by Wnt signaling. J Bone Miner Res 2007, 22:1913-1923.
34. Maeda K., Kobayashi Y., Udagawa N., Uehara S., Ishihara A., Mizoguchi T., et al. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis. Nat Med 2012, 18:405-412.
35. Styrkarsdottir U., Halldorsson B.V., Gudbjartsson D.F., Tang N.L., Koh J.M., Xiao S.M., et al. European bone mineral density loci are also associated with BMD in East-Asian populations. PLoS One 2010, 5:e13217.
36. Rivadeneira F., Styrkarsdottir U., Estrada K., Halldorsson B.V., Hsu Y.H., Richards J.B., et al. Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet 2009, 41:1199-1206.
37. Fu J., Ivy Yu H.M., Maruyama T., Mirando A.J., Hsu W. Gpr177/mouse Wntless is essential for Wnt-mediated craniofacial and brain development. Dev Dyn 2011.
38. Zhu X., Zhu H., Zhang L., Huang S., Cao J., Ma G., et al. Wls-mediated Wnts differentially regulate distal limb patterning and tissue morphogenesis. Dev Biol 2012.
39. Fu J., Jiang M., Mirando A.J., Yu H.M., Hsu W. Reciprocal regulation of Wnt and Gpr177/mouse Wntless is required for embryonic axis formation. Proc Natl Acad Sci USA 2009, 106:18598-18603.
40. Myung P.S., Takeo M., Ito M., Atit R.P. Epithelial Wnt ligand secretion is required for adult hair follicle growth and regeneration. J Invest Dermatol 2012.
41. Zhong Z., Zylstra-Diegel C.R., Schumacher C.A., Baker J.J., Carpenter A.C., Rao S., et al. Wntless functions in mature osteoblasts to regulate bone mass. Proc Natl Acad Sci USA 2012, 109:E2197-E2204.
42. Zha L., Hou N., Wang J., Yang G., Gao Y., Chen L., et al. Collagen1alpha1 promoter drives the expression of Cre recombinase in osteoblasts of transgenic mice. J Genet Genomics 2008, 35:525-530.
43. Tan X., Weng T., Zhang J., Wang J., Li W., Wan H., et al. Smad4 is required for maintaining normal murine postnatal bone homeostasis. J Cell Sci 2007, 120:2162-2170.
44. Dacquin R., Starbuck M., Schinke T., Karsenty G. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast. Dev Dyn 2002, 224:245-251.
45. Harada N., Tamai Y., Ishikawa T., Sauer B., Takaku K., Oshima M., et al. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J 1999, 18:5931-5942.
46. Bouxsein M.L., Boyd S.K., Christiansen B.A., Guldberg R.E., Jepsen K.J., Muller R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 2010, 25:1468-1486.
47. Jacquin C., Gran D.E., Lee S.K., Lorenzo J.A., Aguila H.L. Identification of multiple osteoclast precursor populations in murine bone marrow. J Bone Miner Res 2006, 21:67-77.
48. Feng X., McDonald J.M. Disorders of bone remodeling. Annu Rev Pathol 2011, 6:121-145.
49. Mendez-Ferrer S., Michurina T.V., Ferraro F., Mazloom A.R., Macarthur B.D., Lira S.A., et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-834.
50. Zhang M., Xuan S., Bouxsein M.L., von Stechow D., Akeno N., Faugere M.C., et al. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 2002, 277:44005-44012.
51. Boban I., Jacquin C., Prior K., Barisic-Dujmovic T., Maye P., Clark S.H., et al. The 3.6 kb DNA fragment from the rat Col1a1 gene promoter drives the expression of genes in both osteoblast and osteoclast lineage cells. Bone 2006, 39:1302-1312.
52. Coskun S., Hirschi K.K. Establishment and regulation of the HSC niche: roles of osteoblastic and vascular compartments. Birth Defects Res C Embryo Today 2010, 90:229-242.